A Study Of Paachana Modality In The Patients Of Dyslipidaemia

A Study On Dashavidha Langhana In Perspective Of Autophagy To Assess The Role Of Paachana Modality To Cause Autophagy In Patients Of Medo Dushti (Dyslipidaemia) - autophagy

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/04/024513

Enrollment

Registered

2020-04-08

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

Intervention1: musta churna: Oral Administration Of 3gm twice daily empty stomach Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: Total Cholesterol (201-300 mg/dl) Serum TGLs (161mg/dl or more) Serum HDL (below 40mg/dl) Serum LDL (131mg/dl or more) Serum VLDL (41mg/dl or more)

Exclusion criteria

Exclusion criteria: Patients Who Are Under Conventional Medications. Subjects With Diabetes. Patients With Grave Disease, Psychological Disorders. Patients With Hypothyroidism And Other Metabolic Disorders. Patients With Cardio Vascular Diseases Like Hypertension And Other Severe Conditions.

Design outcomes

Primary

Measure	Time frame
Total Cholesterol Less Then 200mg/dl Along With The Assessment Of Samyaka Of Lakshana Of LanghanaTimepoint: 60 days	—

Secondary

Measure	Time frame
To Improve The Quality Of LifeTimepoint: 60 days	—

Countries

India

Contacts

Public ContactDr Meera K Bhojani

All India Institute of Ayurveda

drmaheshkvyas@gmail.com8849802005

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026